73967-2
Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA
Active
73969-8 Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Term Description
The probability risk for trisomy 13 can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal sex chromosome aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
Source: Regenstrief LOINC
Part Descriptions
LP99499-3 Fetal trisomy 13 risk
Trisomy 13 risk refers to the fetus's risk of having trisomy 13. The risk can be estimated based on maternal age as well as prenatal genetic testing of fetal DNA. Trisomy 13, also called Patau syndrome, is caused by the presence of three copies of chromosome 13 in each cell rather than two. Patau syndrome is associated with severe cognitive delay, various forms of congenital heart disease, brain or spinal cord abnormalities, hypotonia, cleft lip and/or palate, and poorly developed eyes. Many liveborn infants with Patau syndrome die within the first weeks of life, and less than 10% survive longer than one year. The general population risk of Trisomy 13 is about 1 in 16,000 live births, but the risk increases with increasing maternal age. [MedlinePlus Condition: trisomy-13]
Source: Regenstrief LOINC, GHR: Trisomy 13
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal trisomy 13 risk
- Property
- Likelihood
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 13 risk Plas.cfDNA Qn
- Display Name
- Trisomy 13 risk Dosage of chromosome-specific cfDNA Qn (cfDNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 13 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.73
- Change Reason
- The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.; Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 9445
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo de trisomía 13: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Riesgo de trisomía 13 fetal: |
fr-FR | French (France) | Risque de trisomie 13 foetale: |
it-IT | Italian (Italy) | Trisomia 13, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 13 Trisomia cromosoma genetica |
pt-BR | Portuguese (Brazil) | Trissomia 13 risco: |
zh-CN | Chinese (China) | 胎儿三体型 13 风险: Synonyms: 三体型 三体细胞 三染色体性 三染色体细胞 分子病理学; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
73824-5 Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
Trisomy 13 (T13) ordinal risk (high/low) can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
Source: Regenstrief LOINC
Part Descriptions
LP99499-3 Fetal trisomy 13 risk
Trisomy 13 risk refers to the fetus's risk of having trisomy 13. The risk can be estimated based on maternal age as well as prenatal genetic testing of fetal DNA. Trisomy 13, also called Patau syndrome, is caused by the presence of three copies of chromosome 13 in each cell rather than two. Patau syndrome is associated with severe cognitive delay, various forms of congenital heart disease, brain or spinal cord abnormalities, hypotonia, cleft lip and/or palate, and poorly developed eyes. Many liveborn infants with Patau syndrome die within the first weeks of life, and less than 10% survive longer than one year. The general population risk of Trisomy 13 is about 1 in 16,000 live births, but the risk increases with increasing maternal age. [MedlinePlus Condition: trisomy-13]
Source: Regenstrief LOINC, GHR: Trisomy 13
Fully-Specified Name
- Component
- Fetal trisomy 13 risk
- Property
- Imp
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 13 risk Plas.cfDNA Ql
- Display Name
- Trisomy 13 risk Dosage of chromosome-specific cfDNA Ql (cfDNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Trisomy 13 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.73
- Change Reason
- The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.; Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 8224
Example Answer List LL2353-2
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 |
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo de trisomía 13: |
es-MX | Spanish (Mexico) | Riesgo de trisomía 13 fetal: |
fr-FR | French (France) | Risque de trisomie 13 foetale: |
it-IT | Italian (Italy) | Trisomia 13, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 13 Trisomia cromosoma genetica |
pt-BR | Portuguese (Brazil) | Trissomia 13 risco: |
uk-UA | Ukrainian (Ukraine) | Трисомія плода 13 ризик: Synonyms: Chromosom; |
zh-CN | Chinese (China) | 胎儿三体型 13 风险: Synonyms: 三体型 三体细胞 三染色体性 三染色体细胞 依次型; |
73968-0 Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Term Description
The probability risk for trisomy 18 can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal sex chromosome aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal trisomy 18 risk
- Property
- Likelihood
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 18 risk Plas.cfDNA Qn
- Display Name
- Trisomy 18 risk Dosage of chromosome-specific cfDNA Qn (cfDNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 18 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.73
- Change Reason
- The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.; Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 9444
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo de trisomía 18 fetal: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Riesgo de trisomía 18 fetal: |
fr-FR | French (France) | Risque de trisomie 18 foetale: |
it-IT | Italian (Italy) | Trisomia 18, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 18 Trisomia cromosoma genetica |
pt-BR | Portuguese (Brazil) | Trissomia 18 risco: |
zh-CN | Chinese (China) | 胎儿三体型 18 风险: Synonyms: 18 三体型综合征风险(危险性、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
73825-2 Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
Trisomy 18 (T18) ordinal risk (high/low) can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Fetal trisomy 18 risk
- Property
- Imp
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 18 risk Plas.cfDNA Ql
- Display Name
- Trisomy 18 risk Dosage of chromosome-specific cfDNA Ql (cfDNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Trisomy 18 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.73
- Change Reason
- The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.; Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 8225
Example Answer List LL2353-2
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 |
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 18 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 18 fetal: |
fr-FR | French (France) | Risque de trisomie 18 foetale: |
it-IT | Italian (Italy) | Trisomia 18, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 18 Trisomia cromosoma genetica |
pt-BR | Portuguese (Brazil) | Trissomia 18 risco: |
uk-UA | Ukrainian (Ukraine) | Трисомія плода 18 ризик: Synonyms: Chromosom; |
zh-CN | Chinese (China) | 胎儿三体型 18 风险: Synonyms: 18 三体型综合征风险(危险性、 |
73970-6 Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Term Description
The probability risk for trisomy 21 can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal sex chromosome aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal trisomy 21 risk
- Property
- Likelihood
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 21 risk Plas.cfDNA Qn
- Display Name
- Trisomy 21 risk Dosage of chromosome-specific cfDNA Qn (cfDNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 21 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.73
- Change Reason
- The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.; Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 9446
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo de trisomía 21 fetal: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Riesgo de trisomía 21 fetal: |
fr-FR | French (France) | Risque de trisomie 21 foetale: |
it-IT | Italian (Italy) | Trisomia 21, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 21 Trisomia cromosoma genetica |
pt-BR | Portuguese (Brazil) | Trissomia 21 risco: |
zh-CN | Chinese (China) | 胎儿三体型 21 风险: Synonyms: 21 三体型综合征(唐氏综合征、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
73966-4 Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
Trisomy 21 (T21) ordinal risk (high/low) can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Fetal trisomy 21 risk
- Property
- Imp
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 21 risk Plas.cfDNA Ql
- Display Name
- Trisomy 21 risk Dosage of chromosome-specific cfDNA Ql (cfDNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Trisomy 21 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.73
- Change Reason
- The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.; Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 8913
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo de trisomía 21 fetal: |
es-MX | Spanish (Mexico) | Riesgo de trisomía 21 fetal: |
fr-FR | French (France) | Risque de trisomie 21 foetale: |
it-IT | Italian (Italy) | Trisomia 21, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 21 Trisomia cromosoma genetica |
pt-BR | Portuguese (Brazil) | Trissomia 21 risco: |
uk-UA | Ukrainian (Ukraine) | Трисомія плода 21 Ризик: Synonyms: Chromosom; |
zh-CN | Chinese (China) | 胎儿三体型 21 风险: Synonyms: 21 三体型综合征(唐氏综合征、 |
88572-3 Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
The ordinal risk interpretation (e.g. high risk/low risk or high probability/low probability) of the fetus having a 22q11.2 deletion based on dosage of chromosome specific cell-free DNA (cf DNA) in maternal plasma that contains both fetal and maternal DNA. Results may also be based on the mother's current age, IVF status (self, non-self, or not applicable), and gestational age. This code is based, but not limited in use to, the submitter's test, the Harmony Prenatal Test, a non-invasive prenatal test for screening of fetal aneuploidy as well as the 22q11.2 deletion.
Source: Regenstrief LOINC
Part Descriptions
LP185776-4 Fetal 22q11.2 deletion risk
22q11.2 deletion syndrome, also known by many other names including DiGeorge syndrome, CATCH22, and velocardiofacial syndrome, is caused by the deletion of a small piece of chromosome 22. 22q11.2 deletion syndrome is associated with variable characteristics including congenital heart disease, recurrent infection due to immune dysfunction, cleft palate and other distinct facial features, cognitive delay and autoimmune disease. The general population risk of 22q11.2 deletion is about 1 in 4,000 live births, and does not change with maternal age. Fetal risk of having 22q11.2 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 22q112-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 22q11.2 deletion syndrome
Fully-Specified Name
- Component
- Fetal 22q11.2 deletion risk
- Property
- Imp
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 22q11.2 del risk Plas.cfDNA Ql
- Display Name
- 22q11.2 del risk Dosage of chromosome-specific cfDNA Ql (cfDNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal 22q11.2 deletion risk
Basic Attributes
- Class
- MOLPATH.DELDUP
- Type
- Laboratory
- First Released
- Version 2.64
- Last Updated
- Version 2.66
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Observation
Example Answer List LL4771-3
Answer | Code | Score | Answer ID |
---|---|---|---|
High probability | LA28478-8 | ||
Low probability | LA28479-6 |
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo de deleción 22q11.2: |
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 22q11.2: |
fr-FR | French (France) | Risque délétion 22q11.2 foetale: |
it-IT | Italian (Italy) | Delezione 22q11.2 rischio: Synonyms: Delezione o duplicazione genica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 22q11.2 染色体缺失风险: Synonyms: 依次型; |
88571-5 Fetal Monosomy X risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
The ordinal risk interpretation (e.g. high risk/low risk or high probability/low probability) of the fetus having monosomy X aneuploidy based on dosage of chromosome specific cell-free DNA (cf DNA) in maternal plasma that contains both fetal and maternal DNA. Results may also be based on the mother's current age, IVF status (self, non-self, or not applicable), and gestational age. This code is based, but not limited in use to, the submitter's test, the Harmony Prenatal Test, a non-invasive prenatal test for screening of fetal aneuploidy.
Source: Regenstrief LOINC
Part Descriptions
LP185775-6 Fetal monosomy X risk
Monosomy X risk refers to the fetus's risk of having monosomy X, also known as Turner syndrome. The risk can be estimated based on gestational age as well as prenatal genetic testing of fetal DNA.Monosomy X is caused by the presence of a single normal copy of chromosome X in each cell rather than 2 normal copies of X or one X and one Y chromosome. In many cases, critical portions of the second X chromosome may be missing rather than the entire chromosome. Turner syndrome is associated with ovarian dysfunction, short stature and other characteristic physical features, and up to half of girls with Turner syndrome have congenital heart disease. Turner syndrome is not associated with cognitive delay. The general population risk of monosomy X is about 1 in 2,500 live female births, and does not change with maternal age. [MedlinePlus Condition: turner-syndrome]
Source: Regenstrief LOINC, GHR: Turner syndrome
Fully-Specified Name
- Component
- Fetal monosomy X risk
- Property
- Imp
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ms X risk Plas.cfDNA Ql
- Display Name
- Monosomy X risk Dosage of chromosome-specific cfDNA Ql (cfDNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Monosomy X Risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.64
- Last Updated
- Version 2.66
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Observation
Example Answer List LL4771-3
Answer | Code | Score | Answer ID |
---|---|---|---|
High probability | LA28478-8 | ||
Low probability | LA28479-6 |
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo de monosomía X: |
es-MX | Spanish (Mexico) | Riesgo de monosomía X fetal: |
fr-FR | French (France) | Risque de monosomie X foetale: |
it-IT | Italian (Italy) | Monosomia X, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di monosomia X |
zh-CN | Chinese (China) | 胎儿单体型 X 风险: Synonyms: 依次型; |
73821-1 Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Term Description
The probability risk for sex chromosome (X & Y) aneuploidy can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal chromosome X & Y aneuploidy risk
- Property
- Likelihood
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Chr X + Y aneup risk Plas.cfDNA Qn
- Display Name
- Chr X and Y aneuploidy risk Dosage of chromosome-specific cfDNA Qn (cfDNA)
- Consumer Name Alpha Get Info
- Fetal Chromosome X and Y Aneuploidy Risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.73
- Change Reason
- The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.; Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 8586
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de aneuploidía fetal de los cromosomas X e Y: |
es-ES | Spanish (Spain) | Riesgo de aneuploidía X e Y: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque d'aneuploïdie foetale chromosome X et Y: |
it-IT | Italian (Italy) | Cromosomi X & Y, aneuploidia, rischio: Synonyms: Aneuploidia dei cromosomi X e Y DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di aneuploidia dei cromosomi X e Y |
pl-PL | Polish (Poland) | Ryzyko aneuploidii chromosomów X & Y u płodu: Synonyms: Aneuploidia chromosomów X i Y Aneuploidia chromosomów X i Y płodu Ryzyko aneuploidii chromosomów X i Y u płodu |
pt-BR | Portuguese (Brazil) | X & Y aneuploide risco: |
zh-CN | Chinese (China) | 胎儿染色体 X 与 Y 非整倍体性风险: Synonyms: 分子病理学; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
73822-9 Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Nominal
Term Description
Sex chromosome (X & Y) analysis to determine gender (XY or XX) or presence of aneuploidy can be determined based on dosage of chromosome specific ccf DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age. The submitter's lab reports results as male fetus, female fetus, or aneuploidy. For aneuploidy cases, the results of the specific findings (e.g. YY, XYY, XXX, etc.) are reported as well.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal chromosome X & Y aneuploidy
- Property
- Find
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Nom
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Chr X + Y aneup Plas.cfDNA
- Display Name
- Chr X and Y aneuploidy Dosage of chromosome-specific cfDNA Nom (cfDNA)
- Consumer Name Alpha Get Info
- Fetal Chromosome X and Y Aneuploidy
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.44
- Last Updated
- Version 2.73
- Change Reason
- The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured. Changed Component from 'X & Y chromosome analysis' to clarify that the purpose of the measurement is to look for aneuploidy.; Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 7043
Example Answer List LL2479-5
Answer | Code | Score | Answer ID |
---|---|---|---|
Male fetus (XY) | LA19938-2 | ||
Female fetus (XX) | LA19939-0 | ||
Aneuploidy | LA19940-8 |
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Aneuploidía fetal de los cromosomas X e Y: |
es-ES | Spanish (Spain) | Aneuploidía de los cromosmas fetales X e Y: |
fr-FR | French (France) | Chromosomes X et Y aneuploïdie foetale: |
it-IT | Italian (Italy) | Cromosomi X & Y, aneuploidia: Synonyms: Aneuploidia dei cromosomi X e Y DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Osservazione Patologia molecolare Plasma Punto nel tempo (episodio) |
pl-PL | Polish (Poland) | Aneuploidia chromosomów X & Y u płodu: Synonyms: Aneuploidia chromosomów X i Y Aneuploidia chromosomów X i Y płodu |
pt-BR | Portuguese (Brazil) | Cromossomos X& Y análise: |
zh-CN | Chinese (China) | 胎儿染色体 X & Y 非整倍体性: Synonyms: 分子病理学; |
75693-2 Fetal sex in Plasma cell-free DNA by Dosage of chromosome specific cell free (cf) DNA
Term Description
The sex of the fetus is determined based on chromosome analysis.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Fetal sex
- Property
- Find
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Nom
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet sex Plas.cfDNA Dosage cfDNA
- Display Name
- Sex Dosage of chromosome-specific cfDNA Nom (cfDNA)
- Consumer Name Alpha Get Info
- Fetal Sex
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 14145
Example Answer List LL2903-4
Answer | Code | Score | Answer ID |
---|---|---|---|
Female fetus | LA21135-1 | ||
Male fetus | LA21134-4 | ||
No result | LA21136-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
73967-2 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Sexo fetal: |
es-MX | Spanish (Mexico) | Sexo fetal: |
fr-FR | French (France) | Sexe foetal: |
it-IT | Italian (Italy) | Sesso fetale: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Osservazione Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿性别: Synonyms: 分子病理学; |